MINNEAPOLIS - Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, announced the ...

Discover how America's richest families lost multi-billion dollar fortunes. Inside the shocking financial downfalls of the ...

Honestly, are you just 'reading through' Chapter 1 of FAR? I was the same at first. When I counted the past released ...

Agility Capital Holding Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI 25-10-01 Agility Capital Holding Inc. Reports Earnings Results for the Second Quarter and Six Months ...

The cancer pipeline gave Moderna's shares a rocket boost. Citi, however, just checked the stock’s price tag and wasn’t exactly impressed.

ITAT Jaipur held Section 263 revision invalid where AO examined Section 28 land acquisition interest and adopted a legally possible view.

Furthermore, the materialization of certain risks described in Chapter 3 (Risk Factors) of the Registration Document and Chapter 2 (Risk Factors) of the Securities Note, as updated in Section 6 of the ...

Summary of the Global Macro EnvironmentWe summarize the major trends defining the current global financial market from three ...

A recent report by Reuters has disrupted the long-standing narrative of uninterrupted growth surrounding China's robotics ...

Decolonial accounting systems could have been imagined twenty years ago, but they would have been much more difficult to ...